Walleye Trading
INFI

Walleye Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Walleye Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-154
Closed – – 5316
2016
Q3 		$0 Buy
+154
New +$237 ﹤0.01% 5571
2015
Q4 		– Sell
-1,741
Closed -$15K – 5817
2015
Q3 		$15K Buy
+1,741
New +$16.1K ﹤0.01% 4222
2015
Q2 		– Sell
-1,968
Closed -$25.3K – 5239
2015
Q1 		$28K Buy
+1,968
New +$30.1K ﹤0.01% 3387

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's INFI Position: Q4 2016 in Review

Walleye Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 154 shares.

Walleye Trading first reported a position in INFI in Q1 2015 and held it in 3 quarters. The position peaked at $28K in Q1 2015. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • Walleye Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Walleye Trading sold 154 Infinity Pharmaceuticals, Inc. shares in Q4 2016.
  • Walleye Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Walleye Trading's Infinity Pharmaceuticals, Inc. position peaked at $28K in Q1 2015.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Walleye Trading's 13F filing for Q4 2016, filed 14 Feb 2017.